Aminopyrimidine heterocyclic compound having adenosine receptor antagonizing activity

The invention provides an aminopyrimidine heterocyclic compound having adenosine receptor antagonizing activity, which comprises the compound and pharmaceutically acceptable salt thereof, various isotopes, various isomers, various crystal form structures and structures as shown in general formula I. The aminopyrimidine heterocyclic compound having adenosine receptor antagonizing activity can be used as an effective antagonist for adenosine receptors and can be used for treating or preventing symptoms caused by adenosine level abnormality.